
Investments
7Latest METIS Innovative News
Apr 10, 2024
News provided by Apr 02, 2024, 12:02 PM ET We are thrilled to have the support of investors who share our vision and recognize the profound impact our technology will have on improving patient outcomes.” — Manning Hanser MIAMI, FL, UNITED STATES, April 2, 2024 / EINPresswire.com / -- Von Vascular, Inc., a leading innovator in the medical device industry, is pleased to announce the successful closure of their first round of financing in December 2023. This achievement solidifies the company’s financial footing and positions it to achieve key milestones in a timely manner. The exceptional speed at which Von Vascular secured this financing underscores the confidence and enthusiasm surrounding the company's groundbreaking technology. Leading this achievement is Metis Innovative, the lead investor in Von Vascular's opening round of financing. Their unwavering support and belief in the company's mission have been instrumental in realizing this success. Brian A. Sidman, CEO of Metis Innovative, expressed his enthusiasm for the collaboration, stating, "It has been an absolute pleasure collaborating with the Von Vascular team. We are incredibly excited about the transformative potential of their technology and look forward to a successful outcome for all involved." Echoing this sentiment, Manning J. Hanser, CEO of Von Vascular, emphasized the significance of this milestone for both the company and the patients it serves. "The successful completion of our first round of financing is a testament to the dedication and expertise of our team," said Hanser. "We are thrilled to have the support of investors who share our vision and recognize the profound impact our technology will have on improving patient outcomes." Von Vascular remains unwavering in its commitment to advancing innovative solutions and bringing life-changing medical devices to market. With this significant milestone behind them, the company looks ahead with optimism and determination as it continues to revolutionize the healthcare landscape. About Von Vascular, Inc. Von Vascular, Inc. is a leading medical device company dedicated to revolutionizing vascular health through innovative technologies. With a focus on improving patient outcomes and advancing the standard of care, Von Vascular is committed to delivering cutting-edge solutions that address unmet medical needs in the cardiovascular field. For more information, visit vonvascular.io . ###
METIS Innovative Investments
7 Investments
METIS Innovative has made 7 investments. Their latest investment was in Synchron as part of their Series D on November 06, 2025.
METIS Innovative Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/6/2025 | Series D | Synchron | $200M | No | ARCH Venture Partners, Bezos Expeditions, Double Point Ventures, IQT, K5 Global Technology, Khosla Ventures, National Reconstruction Fund Corporation, Neuro Technology Investors, Protocol Labs Venture, Qatar Investment Authority, and T.Rx Capital | 2 |
3/17/2025 | Series A | |||||
12/16/2024 | Series A | |||||
12/1/2023 | Seed | |||||
8/11/2021 | Seed VC |
Date | 11/6/2025 | 3/17/2025 | 12/16/2024 | 12/1/2023 | 8/11/2021 |
|---|---|---|---|---|---|
Round | Series D | Series A | Series A | Seed | Seed VC |
Company | Synchron | ||||
Amount | $200M | ||||
New? | No | ||||
Co-Investors | ARCH Venture Partners, Bezos Expeditions, Double Point Ventures, IQT, K5 Global Technology, Khosla Ventures, National Reconstruction Fund Corporation, Neuro Technology Investors, Protocol Labs Venture, Qatar Investment Authority, and T.Rx Capital | ||||
Sources | 2 |
Loading...